The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Mutational signatures associated with tobacco smoking in human cancer
Open accessPublished version of a preprint
Abstract
Tobacco smoking increases the risk of at least 17 classes of human cancer. We analyzed somatic mutations and DNA methylation in 5243 cancers of types for which tobacco smoking confers an elevated risk. Smoking is associated with increased mutation burdens of multiple distinct mutational signatures, which contribute to different extents in different cancers. One of these signatures, mainly found in cancers derived from tissues directly exposed to tobacco smoke, is attributable to misreplication of DNA damage caused by tobacco carcinogens. Others likely reflect indirect activation of DNA editing by APOBEC cytidine deaminases and of an endogenous clocklike mutational process. Smoking is associated with limited differences in methylation. The results are consistent with the proposition that smoking increases cancer risk by increasing the somatic mutation load, although direct evidence for this mechanism is lacking in some smoking-related cancer types.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TMB measured by comprehensive genomic profiling is comparable to measurements by whole exome sequencing and is typically higher in smoking associated lung cancer due to tobacco carcinogenesis”
From Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC (2018) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
Self-citationAn integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Robust regression using iteratively reweighted least-squares.
Holland, P. W., & Welsch, R. E. (1977) · Communications in Statistics - Theory and Methods · doi:10.1080/03610927708827533 · Cited by 2,115
Mutational Processes Molding the Genomes of 21 Breast Cancers
Nik-Zainal, S., Alexandrov, L. B., Wedge, D. C., Van Loo, P., Greenman, C. D., Raine, K., Jones, D., Hinton, J., Marshall, J., Stebbings, L. A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.04.024 · Cited by 1,909
Self-citationHuber, P. J., & Ronchetti, E. M. (2009) · Wiley series in probability and statistics · doi:10.1002/9780470434697 · Cited by 1,823
Schulze, K., Imbeaud, S., Letouzé, E., Alexandrov, L. B., Calderaro, J., Rebouissou, S., Couchy, G., Meiller, C., Shinde, J., Soysouvanh, F., et al. (2015) · Nature Genetics · doi:10.1038/ng.3252 · Cited by 1,803
Self-citationMapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing
Imielinski, M., Berger, A. H., Hammerman, P. S., Hernandez, B., Pugh, T. J., Hodis, E., Cho, J., Suh, J., Capelletti, M., Sivachenko, A., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.029 · Cited by 1,789
Preferential Formation of Benzo[ a ]pyrene Adducts at Lung Cancer Mutational Hotspots in P53
Denissenko, M. F., Pao, A., Tang, M.-S., & Pfeifer, G. P. (1996) · Science · doi:10.1126/science.274.5286.430 · Cited by 1,650
Tobacco carcinogens, their biomarkers and tobacco-induced cancer
Hecht, S. S. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1190 · Cited by 1,551
The Age Distribution of Cancer and a Multi-stage Theory of Carcinogenesis
Armitage, P., & Doll, R. (1954) · British Journal of Cancer · doi:10.1038/bjc.1954.1 · Cited by 1,549
DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome
Ley, T. J., Mardis, E. R., Ding, L., Fulton, B., McLellan, M. D., Chen, K., Dooling, D. J., Dunford-Shore, B. H., McGrath, S. D., Hickenbotham, M. T., et al. (2008) · Nature · doi:10.1038/nature07485 · Cited by 1,434
The age distribution of cancer and a multi-stage theory of carcinogenesis
Armitage, P., & Doll, R. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602297 · Cited by 1,292
Deciphering Signatures of Mutational Processes Operative in Human Cancer
Alexandrov, L. B., Nik‐Zainal, S., Wedge, D. C., Campbell, P. J., & Stratton, M. R. (2013) · Cell Reports · doi:10.1016/j.celrep.2012.12.008 · Cited by 1,277
Self-citationGerlinger, M., Horswell, S. D., Larkin, J., Rowan, A., Salm, M., Varela, I., Fisher, R. A., McGranahan, N., Matthews, N., Santos, C. R., et al. (2014) · Nature Genetics · doi:10.1038/ng.2891 · Cited by 1,236
Effects of cigarette smoke on the immune system
Sopori, M. L. (2002) · Nature reviews. Immunology · doi:10.1038/nri803 · Cited by 1,219
Allele-specific copy number analysis of tumors
Loo, P. V., Nord, S., Lingjærde, O. C., Russnes, H. G., Rye, I. H., Sun, W., Weigman, V., Marynen, P., Zetterberg, A., Naume, B., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1009843107 · Cited by 1,192
Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers
Govindan, R., Ding, L., Griffith, M., Subramanian, J., Dees, N. D., Kanchi, K., Maher, C. A., Fulton, R. S., Fulton, L., Wallis, J. W., et al. (2012) · Cell · doi:10.1016/j.cell.2012.08.024 · Cited by 1,161
A review of human carcinogens–Part E: tobacco, areca nut, alcohol, coal smoke, and salted fish
Secretan, B., Straif, K., Baan, R., Grosse, Y., El Ghissassi, F., Bouvard, V., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70326-2 · Cited by 1,114
Clock-like mutational processes in human somatic cells
Alexandrov, L. B., Jones, P. H., Wedge, D. C., Sale, J. E., Campbell, P. J., Nik‐Zainal, S., & Stratton, M. R. (2015) · Nature Genetics · doi:10.1038/ng.3441 · Cited by 1,065
Self-citationp53 and Human Cancer: The First Ten Thousand Mutations
Hainaut, P. L., & Hollstein, M. C. (1999) · Advances in cancer research · doi:10.1016/s0065-230x(08)60785-x · Cited by 999
Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants
Fu, W., O’Connor, T. D., Jun, G., Kang, H. M., Abecasis, G. R., Leal, S. M., Gabriel, S., Rieder, M. J., Altshuler, D., Shendure, J., et al. (2012) · Nature · doi:10.1038/nature11690 · Cited by 969
Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Bolli, N., Avet-Loiseau, H., Wedge, D. C., Van Loo, P., Alexandrov, L. B., Martincorena, I., Dawson, K. J., Iorio, F., Nik-Zainal, S., Bignell, G. R., et al. (2014) · Nature Communications · doi:10.1038/ncomms3997 · Cited by 875
Self-citationMechanisms underlying mutational signatures in human cancers
Helleday, T., Eshtad, S., & Nik‐Zainal, S. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3729 · Cited by 861
Self-citationSubclonal diversification of primary breast cancer revealed by multiregion sequencing
Yates, L. R., Gerstung, M., Knappskog, S., Desmedt, C., Gundem, G., Loo, P. V., Aas, T., Alexandrov, L. B., Larsimont, D., Davies, H., et al. (2015) · Nature Medicine · doi:10.1038/nm.3886 · Cited by 833
Self-citationA New Theory on the Cancer-inducing Mechanism
Nordling, C. O. (1953) · British Journal of Cancer · doi:10.1038/bjc.1953.8 · Cited by 779
Fujimoto, A., Furuta, M., Totoki, Y., Tsunoda, T., Kato, M., Shiraishi, Y., Tanaka, H., Taniguchi, H., Kawakami, Y., Ueno, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3547 · Cited by 704
Self-citationTiming, rates and spectra of human germline mutation
Rahbari, R., Wüster, A., Lindsay, S., Hardwick, R. J., Alexandrov, L. B., Turki, S. H. A., Dominiczak, A. F., Morris, A. D., Porteous, D. J., Smith, B. H., et al. (2015) · Nature Genetics · doi:10.1038/ng.3469 · Cited by 641
Self-citationPesch, B., Kendzia, B., Gustavsson, P., Jöckel, K., Johnen, G., Pohlabeln, H., Olsson, A., Ahrens, W., Gross, I. M., Brüske, I., et al. (2012) · International Journal of Cancer · doi:10.1002/ijc.27339 · Cited by 509
APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity
Swanton, C., McGranahan, N., Starrett, G. J., & Harris, R. S. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0344 · Cited by 492
Mutational signatures: the patterns of somatic mutations hidden in cancer genomes
Alexandrov, L. B., & Stratton, M. R. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.014 · Cited by 488
Self-citationOnly three driver gene mutations are required for the development of lung and colorectal cancers
Tomasetti, C., Marchionni, L., Nowak, M. A., Parmigiani, G., & Vogelstein, B. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421839112 · Cited by 412
Somatic ERCC2 mutations are associated with a distinct genomic signature in urothelial tumors
Kim, J., Mouw, K. W., Polak, P. P., Braunstein, L. Z., Kamburov, A., Tiao, G., Kwiatkowski, D. J., Rosenberg, J. E., Allen, E. M. V., D’Andrea, A. D., et al. (2016) · Nature Genetics · doi:10.1038/ng.3557 · Cited by 411
Roberts, S. A., Sterling, J. F., Thompson, C., Harris, S. F., Mav, D., Shah, R., Klimczak, L. J., Kryukov, G. V., Malc, E. P., Mieczkowski, P. A., et al. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.03.030 · Cited by 405
A Note on Computing Robust Regression Estimates Via Iteratively Reweighted Least Squares
Street, J. O., Carroll, R. J., & Ruppert, D. (1988) · The American Statistician · doi:10.1080/00031305.1988.10475548 · Cited by 380
Genome sequencing of normal cells reveals developmental lineages and mutational processes
Behjati, S., Huch, M., van Boxtel, R., Karthaus, W., Wedge, D. C., Tamuri, A. U., Martincorena, I., Petljak, M., Alexandrov, L. B., Gundem, G., et al. (2014) · Nature · doi:10.1038/nature13448 · Cited by 357
Self-citationOrigins and functional consequences of somatic mitochondrial DNA mutations in human cancer
Ju, Y. S., Alexandrov, L. B., Gerstung, M., Martincorena, I., Nik-Zainal, S., Ramakrishna, M., Davies, H. R., Papaemmanuil, E., Gundem, G., Shlien, A., et al. (2014) · eLife · doi:10.7554/elife.02935 · Cited by 355
Self-citationTargeting of Lung Cancer Mutational Hotspots by Polycyclic Aromatic Hydrocarbons
Smith, L. E., Denissenko, M. F., Bennett, W. P., Li, H., Amin, S., Tang, M., & Pfeifer, G. P. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.803 · Cited by 307
Smoking-related DNA and protein adducts in human tissues
Phillips, D. H. (2002) · Carcinogenesis · doi:10.1093/carcin/23.12.1979 · Cited by 296
Self-citationEpidemiology of Bladder Cancer
Silverman, D. T., Hartge, P. A., Morrison, A. S., & Devesa, S. S. (1992) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(18)30360-5 · Cited by 288
Nik-Zainal, S., Wedge, D. C., Alexandrov, L. B., Petljak, M., Butler, A. P., Bolli, N., Davies, H. R., Knappskog, S., Martin, S., Papaemmanuil, E., et al. (2014) · Nature Genetics · doi:10.1038/ng.2955 · Cited by 277
Self-citationLe Calvez, F., Mukeria, A., Hunt, J. D., Kelm, O., Hung, R. J., Tanière, P., Brennan, P., Boffetta, P., Zaridze, D. G., & Hainaut, P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0551 · Cited by 273
The genome as a record of environmental exposure
Nik‐Zainal, S., Kucab, J. E., Morganella, S., Głodzik, D., Alexandrov, L. B., Arlt, V. M., Weninger, A., Hollstein, M. C., Stratton, M. R., & Phillips, D. H. (2015) · Mutagenesis · doi:10.1093/mutage/gev073 · Cited by 209
Self-citationTeschendorff, A. E., Yang, Z., Wong, A., Pipinikas, C., Jiao, Y., Jones, A., Anjum, S., Hardy, R., Salvesen, H. B., Thirlwell, C., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.1053 · Cited by 200
Transmissible Dog Cancer Genome Reveals the Origin and History of an Ancient Cell Lineage
Murchison, E. P., Wedge, D. C., Alexandrov, L. B., Fu, B., Martincorena, I., Ning, Z., Tubío, J. M. C., Werner, E., Allen, J., Nardi, A. B. D., et al. (2014) · Science · doi:10.1126/science.1247167 · Cited by 193
Self-citationA mutational signature in gastric cancer suggests therapeutic strategies
Alexandrov, L. B., Nik‐Zainal, S., Siu, H. C., Leung, S. Y., & Stratton, M. R. (2015) · Nature Communications · doi:10.1038/ncomms9683 · Cited by 178
Self-citationAgudo, A., Bonet, C., Travier, N., Gonzalez, C. A., Vineis, P., Bueno-de-Mesquita, H. B., Trichopoulos, D., Boffetta, P., Clavel‐Chapelon, F., Boutron‐Ruault, M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.41.0183 · Cited by 171
Self-citationDNA and protein adducts in human tissues resulting from exposure to tobacco smoke
Phillips, D. H., & Venitt, S. (2012) · International Journal of Cancer · doi:10.1002/ijc.27827 · Cited by 144
Self-citationOn a Robust Correlation Coefficient
Abdullah, M. B. (1990) · Journal of the Royal Statistical Society Series D (The Statistician) · doi:10.2307/2349088 · Cited by 98
Formation and repair of DNA lesions in thep53 gene: Relation to cancer mutations?
Pfeifer, G. P., & Denissenko, M. F. (1998) · Environmental and Molecular Mutagenesis · doi:10.1002/(sici)1098-2280(1998)31:3 · Cited by 63
Selective clonal expansion and microenvironmental permissiveness in tobacco carcinogenesis
Rubin, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205800 · Cited by 43
Understanding the origins of human cancer
Alexandrov, L. B. (2015) · Science · doi:10.1126/science.aad7363 · Cited by 35
Self-citationWagener, R., Alexandrov, L. B., Montesinos‐Rongen, M., Schlesner, M., Haake, A., Drexler, H. G., Richter, J., Bignell, G. R., McDermott, U., & Siebert, R. (2015) · Leukemia · doi:10.1038/leu.2015.22 · Cited by 28
Self-citation
Flagged first, then by citations
Research works printed but not linked: 2
- D. H. Phillips in The Cancer Handbook M. R. Allison Ed. (Macmillan 2002) pp. 293–306.
- V. Barnett T. Lewis Outliers in Statistical Data (Wiley Series in Probability and Mathematical Statistics: Applied Probability and Statistics Wiley ed. 3 1994).
Cited by
Sorted by citations
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Chalmers, Z. R., Connelly, C. F., Fabrizio, D., Gay, L., Ali, S. M., Ennis, R., Schrock, A., Campbell, B., Shlien, A., Chmielecki, J., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0424-2 · Cited by 3,519
Pan-cancer analysis of whole genomes
The ICGC/TCGA Pan-Cancer Analysis of Whole Genomes Consortium, Aaltonen, L. A., Abascal, F., Abeshouse, A., Aburatani, H., Adams, D. J., Agrawal, N., Ahn, K. S., Ahn, S.-M., Aikata, H., et al. (2020) · Nature · doi:10.1038/s41586-020-1969-6 · Cited by 3,064
Self-citationKastenhuber, E. R., & Lowe, S. W. (2017) · Cell · doi:10.1016/j.cell.2017.08.028 · Cited by 1,906
A compendium of mutational cancer driver genes
Martínez-Jiménez, F., Muiños, F., Sentís, I., Deu-Pons, J., Reyes-Salazar, I., Arnedo-Pac, C., Mularoni, L., Pich, O., Bonet, J., Kranas, H., et al. (2020) · Nature reviews. Cancer · doi:10.1038/s41568-020-0290-x · Cited by 1,340
The Challenges of Tumor Mutational Burden as an Immunotherapy Biomarker
Jardim, D. L., Goodman, A., de Melo Gagliato, D., & Kurzrock, R. (2021) · Cancer Cell · doi:10.1016/j.ccell.2020.10.001 · Cited by 1,192
Metadata
- Authors
- Alexandrov, L. B., Ju, Y. S., Haase, K., Van Loo, P., Martincorena, I., Nik-Zainal, S., Totoki, Y., Fujimoto, A., Nakagawa, H., Shibata, T., Campbell, P. J., Vineis, P., Phillips, D. H., & Stratton, M. R.
- Affiliations
- Los Alamos National Laboratory (US)
- Korea Advanced Institute of Science and Technology (KR)
- The Francis Crick Institute (GB)
- The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK.
- Cancer Genome Project, Wellcome Trust Sanger Institute, Hinxton CB10 1SA, Cambridgeshire, UK.
- National Cancer Center Research Institute (JP)
- Kyoto University (JP)
- RIKEN Center for Integrative Medical Sciences (JP)
- Institute of Medical Science, The University of Tokyo (JP)
- University of Cambridge (GB)
- Public Health England (GB)
- King's College London (GB)
- Wellcome Sanger Institute (GB)
- Corresponding author
- Alexandrov, Ludmil B.
- Stratton, Michael R.
- ORCID
- Venue
- Science
- Published
- 2016-11-04
- Volume
- 354
- Issue
- 6312
- Pages
- 618-622
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- PMC
- PMC6141049
- OpenAlex
- W2547187744
- Cited by
- 1,100
- References
- 54
- Citations by year
- 2026: 70 · 2025: 89 · 2024: 103 · 2023: 121 · 2022: 115 · 2021: 148 · 2020: 149 · 2019: 117 · 2018: 95 · 2017: 90 · 2016: 3
- FWCI
- 42.36
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- Science (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Figshare (submittedVersion, cc-by)
- Research Portal (King's College London) (submittedVersion, other-oa)
- Lirias (submittedVersion)
- OSTI OAI (U.S. Department of Energy Office of Scientific and Technical Information) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion)
- Funders
- Wellcome Trust Intermediate Fellowship (WT100183MA)
- Wellcome Trust Senior Clinical Research Fellowship (WT088340MA)
- U.S. Department of Energy (DOE) National Nuclear Security Administration (DE-AC52-06NA25396)
- Francis Crick Institute
- UK MRC (FC001202)
- Cancer Research UK (FC001202, C313/A14329)
- Wellcome Trust (98051, FC001202, 101126/Z/13/Z, 101126/B/13/Z)
- National Institute for Health Research (NIHR)
- EXPOSOMICS (308610-FP7)
- Japan Agency for Medical Research and Development (15ck0106094h0002)
- National Cancer Center Research and Development Funds (26-A-5)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Carcinogens and Genotoxicity Assessment
- Keywords
- smoking, mutational signatures, somatic mutations, DNA methylation, tobacco-related cancer, APOBEC cytidine deaminases, tobacco carcinogens, mutational burden, cancer risk
- MeSH terms
- APOBEC Deaminases, Carcinogens, DNA Damage, Humans, Mutation, Neoplasms, Risk, Smoking, Tobacco Products, Nicotiana, CpG Islands, DNA Methylation, Exome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
